Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of allicin on the intestinal microbiota and production efficiency in selected farm animals.

Journal of veterinary research·2026
Same author

Extrachromosomal DNA Amplification as a Prognostic Factor for Cancer.

Journal of personalized medicine·2026
Same author

Nucleotide Variant in the <i>SLC26A9</i> Gene in Two Siblings with Cystic Fibrosis.

Journal of clinical medicine·2026
Same author

Effect of frozen storage period and temperature on the physicochemical and microbiological quality of veal.

Meat science·2026
Same author

"Variant matters": the impact of ALK fusion subtypes on progression and response in non-small-cell lung cancer-data from clinical practice from Polish centers.

Translational lung cancer research·2026
Same author

Studies on the anticonvulsant potential of 6-gingerol, an active ingredient of ginger rhizome.

Frontiers in pharmacology·2026

Related Experiment Video

Updated: Jun 27, 2026

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

Clostridiaceae in Cancer Management.

Julia Banaszkiewicz1, Paweł Krawczyk2, Tomasz Grenda3

  • 1Student Scientific Circle at the Chair of Pneumonology, Oncology and Allergology, Medical University of Lublin, Lublin, Poland.

Oncology Research
|June 26, 2026
PubMed
Summary

Anaerobic Clostridiaceae bacteria show promise as an innovative cancer therapy. These microbes selectively target tumors, offering a novel approach to combat rising cancer incidence and mortality.

Keywords:
CancerClostridiaceaesporestreatment

More Related Videos

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Related Experiment Videos

Last Updated: Jun 27, 2026

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Area of Science:

  • Oncology
  • Microbiology
  • Biotechnology

Background:

  • Rising cancer incidence necessitates novel therapeutic strategies beyond traditional methods.
  • Tumor microenvironment heterogeneity and hypoxic zones present challenges for current cancer treatments.
  • Anaerobic bacteria, particularly Clostridiaceae, are emerging as potential cancer therapeutics due to their tumor-specific growth.

Purpose of the Study:

  • To review the role and potential of Clostridiaceae bacteria in developing innovative anticancer therapies.
  • To highlight the advantages of Clostridiaceae bacteria, including selective tumor targeting and immune response activation.
  • To discuss the application of genetically engineered Clostridiaceae for targeted drug delivery and synergistic effects with conventional treatments.

Main Methods:

  • Review of scientific literature on Clostridiaceae bacteria in cancer therapy.
  • Analysis of Clostridiaceae properties, including selective colonization of hypoxic tumor regions.
  • Examination of genetic engineering techniques applied to Clostridiaceae for enhanced therapeutic efficacy.

Main Results:

  • Clostridiaceae bacteria, like Clostridium novyi-NT, selectively colonize hypoxic tumor areas without affecting healthy tissues.
  • These bacteria produce toxins and enzymes that induce cancer cell lysis and stimulate immune responses.
  • Genetically modified Clostridiaceae can activate prodrugs within tumors, reducing systemic toxicity.
  • Combination therapy with Clostridiaceae spores and conventional treatments (chemotherapy, radiotherapy, immunotherapy) demonstrates significant synergistic effects.

Conclusions:

  • Clostridiaceae bacteria represent a promising platform for innovative cancer treatment strategies.
  • Their ability to target hypoxic tumor regions and activate anti-tumor immunity offers a unique therapeutic advantage.
  • Further research and development of Clostridiaceae-based therapies hold significant potential for improving cancer patient outcomes.